QUIDELORTHO CORP Repayments of Long-Term Debt
QUIDELORTHO CORP (QDEL) reported Repayments of Long-Term Debt of $42.00 million for the 6-month period ending 2026-06-28, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2026-08-07
- QUIDELORTHO CORP repayments of long-term debt for the quarter ending 2026-06-28 was $19.60M, a 45.56% decline year-over-year.
- QUIDELORTHO CORP repayments of long-term debt for the quarter ending 2026-03-29 was $22.40M, a 37.78% decline year-over-year.
- QUIDELORTHO CORP repayments of long-term debt for the quarter ending 2025-12-28 was $1.60M, a 95.56% decline year-over-year.
- QUIDELORTHO CORP repayments of long-term debt for the quarter ending 2025-09-28 was $2.22B, a 67039.39% increase year-over-year.
- QUIDELORTHO CORP repayments of long-term debt for fiscal 2025 was $2.29B, a 1500.84% increase from fiscal 2024.
- QUIDELORTHO CORP repayments of long-term debt for fiscal 2024 was $143.00M, a 37.28% decline from fiscal 2023.
- QUIDELORTHO CORP repayments of long-term debt for fiscal 2023 was $228.00M.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 12 month |
|---|---|---|---|---|
| 2026-06-28 | $19.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $42.00M 10-Q · filed 2026-08-07 | $43.60M derived: sum of 3 quarters · filed 2026-08-07 | $2.26B derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-29 | $22.40M 10-Q · filed 2026-05-06 | $24.00M derived: sum of 2 quarters · filed 2026-05-06 | $2.24B derived: sum of 3 quarters · filed 2026-05-06 | $2.28B derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-28 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $2.22B derived: sum of 2 quarters · filed 2026-02-19 | $2.25B derived: sum of 3 quarters · filed 2026-08-07 | $2.29B 10-K · filed 2026-02-19 |
| 2025-09-28 | $2.22B derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $2.25B derived: sum of 2 quarters · filed 2026-08-07 | $2.29B 10-Q · filed 2025-11-06 | $2.32B derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-29 | $36.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $72.00M 10-Q · filed 2026-08-07 | $108.00M derived: sum of 3 quarters · filed 2026-08-07 | $111.30M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-30 | $36.00M 10-Q · filed 2026-05-06 | $72.00M derived: sum of 2 quarters · filed 2026-05-06 | $75.30M derived: sum of 3 quarters · filed 2026-05-06 | $127.10M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-29 | $36.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $39.30M derived: sum of 2 quarters · filed 2026-02-19 | $91.10M derived: sum of 3 quarters · filed 2026-02-19 | $143.00M 10-K · filed 2026-02-19 |
| 2024-09-29 | $3.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $55.10M derived: sum of 2 quarters · filed 2025-11-06 | $107.00M 10-Q · filed 2025-11-06 | $159.30M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | $51.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $103.70M 10-Q · filed 2025-08-06 | $156.00M derived: sum of 3 quarters · filed 2026-02-19 | $207.90M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | $51.90M 10-Q · filed 2025-05-08 | $104.20M derived: sum of 2 quarters · filed 2026-02-19 | $156.10M derived: sum of 3 quarters · filed 2026-02-19 | $228.00M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | $52.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $104.20M derived: sum of 2 quarters · filed 2026-02-19 | $176.10M derived: sum of 3 quarters · filed 2026-02-19 | $228.00M 10-K · filed 2026-02-19 |
| 2023-10-01 | $51.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $123.80M derived: sum of 2 quarters · filed 2024-11-08 | $175.70M 10-Q · filed 2024-11-08 | |
| 2023-07-02 | $71.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $123.80M 10-Q · filed 2024-08-01 | ||
| 2023-04-02 | $51.90M 10-Q · filed 2024-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |